What’s New in PAH in 2024
Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.
Is this SOB my problem or yours? : Referral to Cardiology
Imposter Syndrome: Who me?
Earn Free CME with APAPP
The Association of Pulmonary Advanced Practice Providers (APAPP) is thrilled to announce two exciting new ways to earn free CME credits! Listen […]
Understanding MAC
Biologics in COPD: Why, when, and who
One Year of APAPP Podcasts
Happy 1st Birthday, APAPP Podcast! We are thrilled to celebrate the one-year anniversary of the APAPP Podcast! Over the past year, our host has guided us through numerous enlightening topics related to both clinical practice and career development within the field.
Inhaler 101
APAPP Board Member Tyler Kuhk an adult gerontology nurse practitioner, discusses the complexities of inhalers and the various types of inhaler devices used in respiratory care. Stream our latest podcast episode on Apple Podcasts, Spotify, and YouTube.